Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Di...( CHENGDU China May 20 /Xinhua-- Ti...),Health

CHENGDU, China, May 20 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it signed over 60 new distribution agreements with a total of 15 regional distributors, including both new and previously contracted distributors.

Many of these agreements, which are for a term of one year, were signed with several of the Company's top 10 distributors from 2007. Newly engaged distributors include Sichuan Kelun Medicine & Trade Co., Ltd. and Zhejiang Huadong Medicine Co., Ltd. Based upon the results of previous years' agreements, and expected results from the new agreements, management believes that all of the 2008 distribution agreements have the potential to generate over an aggregate of $10 million in product orders, which would represent a 20% increase over the results received from last year's distribution agreements.

The distribution agreements cover 27 existing products from last year's agreements and 1 newly launched drug, the Azithromycin Dispersible Tablet, which is used for Upper and lower respiratory tract infections and other bacterial infections in the skin and reproductive system. The Company's two flagship products, Arpu Shuangxin Oral Liquid and Ginkgo Mihuan Oral Liquid, along with any other new drugs that we launch during 2008 are not included in the distribution agreements discussed herein.

"This accomplishment is significant for several reasons and demonstrates Tianyin Pharmaceutical's ability to expand its geographic footprint and distribution channels for both existing and new products. This will help us to gain incremental market share, which will ultimately drive future revenue growth. We recently initiated production to fulfill orders for the 28 products referenced above and anticipate initial contribution from these agreements during the fourth quarter of f
'/>"/>